Valuation: H&R GmbH & Co. KGaA

Market Cap 20Cr 23Cr 19Cr 17Cr 33Cr 2.21TCr 34Cr 224.22Cr 87Cr 1.09TCr 87Cr 85Cr 3.75TCr P/E 2026 *
34.7x
P/E 2027 * 25.6x
Enterprise Value 36Cr 41Cr 33Cr 31Cr 58Cr 3.91TCr 59Cr 396.45Cr 154.12Cr 1.92TCr 154.29Cr 150.98Cr 6.63TCr EV / Sales 2026 *
0.28x
EV / Sales 2027 * 0.27x
Free-Float
21.97%
Yield 2026 *
0.92%
Yield 2027 * 0.92%
15/05 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
31/03 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
28/01 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
15/11 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
14/11 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25/25/25 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
15/25/15 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
16/25/16 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
14/25/14 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
17/25/17 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
09/25/09 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
27/25/27 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
27/25/27 H&R GmbH & Co. KGaA Announces Postponement of the Publication of the Consolidated Financial Statements and the Annual Report 2024 CI
1 day-2.50%
1 week+14.71%
Current month+9.86%
1 month+14.23%
3 months+34.81%
6 months+27.57%
Current year+27.27%
1 week 4.51
Extreme 4.51
5.68
1 month 4.51
Extreme 4.51
5.68
Current year 3.91
Extreme 3.91
5.68
1 year 3.91
Extreme 3.91
5.68
3 years 3.23
Extreme 3.23
5.68
5 years 3.23
Extreme 3.23
10.35
10 years 3.23
Extreme 3.23
19.58
Manager TitleAgeSince
Chief Executive Officer 61 01/01/2016
Investor Relations Contact - 01/01/2006
Director TitleAgeSince
Chairman 62 17/04/2012
Director/Board Member 71 01/05/2011
Director/Board Member 69 01/05/2011
Change 5-day change 1-year change 3-year change Capi.($)
-2.50%+14.71%+10.53%+2.25% 23Cr
+0.16%+4.30%+12.73%+32.69% 13TCr
0.00%+33.11%+579.31%+173.23% 4.89TCr
-1.33%-2.54%-8.81%-41.98% 4.14TCr
+0.85%-3.64%+26.80%-21.01% 3.19TCr
0.00%-0.96%+26.79%+58.24% 2.2TCr
-9.99%-3.14%+74.14%+262.87% 1.96TCr
-2.23%+0.98%+417.14%+629.62% 1.97TCr
+0.56%-3.47%+23.78%+23.01% 1.85TCr
-1.59%-0.65%+79.30%+2.57% 1.79TCr
Average -1.61%+2.65%+124.17%+112.15% 3.51TCr
Weighted average by Cap. -0.76%+4.26%+121.35%+84.47%

Financials

2026 *2027 *
Net sales 129.35Cr 147.96Cr 118.87Cr 110.8Cr 210.16Cr 14TCr 213.35Cr 1.43TCr 554.78Cr 6.93TCr 555.4Cr 543.47Cr 24TCr 133.02Cr 152.17Cr 122.25Cr 113.95Cr 216.13Cr 14TCr 219.41Cr 1.47TCr 570.54Cr 7.12TCr 571.18Cr 558.91Cr 25TCr
Net income 58.49L 66.9L 53.75L 50.1L 95.03L 64Cr 96.47L 6.45Cr 2.51Cr 31Cr 2.51Cr 2.46Cr 107.9Cr 79.95L 91.46L 73.47L 68.49L 1.3Cr 87Cr 1.32Cr 8.82Cr 3.43Cr 43Cr 3.43Cr 3.36Cr 147.5Cr
Net Debt 16Cr 18Cr 14Cr 13Cr 25Cr 1.7TCr 26Cr 172.23Cr 67Cr 835.77Cr 67Cr 66Cr 2.88TCr 16Cr 18Cr 15Cr 14Cr 26Cr 1.72TCr 26Cr 174.13Cr 68Cr 844.99Cr 68Cr 66Cr 2.91TCr
Logo H&R GmbH & Co. KGaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
1,692
Date Price Change Volume
03/26/03 €5.460 -2.50% 374
02/26/02 €5.600 +5.66% 30,816
01/26/01 €5.300 +6.64% 35,405
30/26/30 €4.970 +1.43% 5,605
29/26/29 €4.900 +2.94% 470
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
5.460EUR
Average target price
4.300EUR
Spread / Average Target
-21.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2HRA Stock